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We compared the analgesic eﬃcacy of spinal and general anaesthesia following transurethral procedures. 97 and 47 patients
underwenttransurethralbladdertumourresection(TUR-B)andtransurethralprostatectomy(TUR-P),respectively.Postoperative
pain was recorded using an 11-point visual analogue scale (VAS). VAS score was greatest at discharge from recovery room for
general anaesthesia (P = 0.027). The pattern changed signiﬁcantly at 8h and 12h for general anaesthesia’s eﬃcacy (P = 0.017 and
P = 0.007, resp.). A higher VAS score was observed in pT2 patients. Patients with resected tumour volume >10cm3 exhibited a
VAS score >3a t8ha n d2 4h( P = 0.050,P = 0.036, resp.). Multifocality of bladder tumours induced more pain overall. It seems
that spinal anaesthesia is more eﬀective during the ﬁrst 2 postoperative hours, while general prevails at later stages and at larger
traumatic surfaces. Finally, we incidentally found that tumour stage plays a signiﬁcant role in postoperative pain, a point that
requires further veriﬁcation.
1.Introduction
Pain management during transurethral procedures is a
major concern. Apart from the standard general anaesthesia,
regional anaesthesia is also extensively applied. Nevertheless,
the administered type of anaesthesia is ultimately based
on the anaesthesiologist’s decision. Regional anaesthesia is
divided in epidural, spinal, and saddle blockade anaesthesia.
Recently, local anesthesia with inﬁltration of the bladder
wall or periprostatic nerve blockage was reported [1–3].
Additionally, sedoanalgesia which is the combination of local
anaesthesiawithsedation oreventheuseofvirtualrealityfor
pain management has been examined [4, 5].
The selection of anaesthesia in a transurethral prostate-
ctomy (TUR-P) or a transurethral bladder tumor resection
(TUR-B) has been investigated meticulously in previous
reports [6–8]. In general, regional or local anaesthesia
demonstrates distinct advantages and disadvantages in terms
of postoperative morbidity [6–8]. However, to our knowl-
edge, there is no study comparing these methods. The aim
of the present study was to compare general and spinal
anaesthesia in terms of postoperative pain mitigation by
recording the patient’s pain perception during the critical
ﬁrst 24 postoperative hours and to investigate a potential
correlation of clinical and pathological data with the pain
induced by the transurethral procedures.
2. Patients andMethods
All patients provided informed consent, before being
included in the study. Distribution of the patients is depicted
in the CONSORT ﬂow diagram [9]( Figure 1). Patient
age and distribution of the population according to stage
and grade of the transitional cell carcinomas (TCC) are
summarized in Table 1.2 ISRN Urology
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Figure 1: Randomization of the patients according to the CONSORT ﬂow diagram.
Conventional transurethral procedures were performed
usingstandardresectoscopesandelectrocautery.Nopreemp-
tive analgesia was administered. Induction to general anaes-
thesia was done with the intravenous (I.V.) administration
of 1-2g/kg of propofol, followed by 1-2mg/kg of fentanyl
along with 1-2mg/kg of suxamethonium. Maintenance of
anaesthesia was achieved with the I.V. administration of
0.5mg/kg of atracurium (N2O at 50% O2) and inhaled
desﬂurane at MAC 1 (Minimum Alveolar Concentration).
Spinal anaesthesia was administered as a single shot of 2mL
bupicaine and 1mL lidocaine without adrenaline. Patients
with bladder or prostatic capsule perforation, which was
identiﬁed intraoperatively, were excluded from the study.
A 22-F, 3-way Dufour catheter was placed in all patients,
and bladder irrigation was standard. Bladder irrigation was
stopped after the completion of the 24-hour observation
period after verifying the absence of intravesical clotting
by manual irrigation and suction. Patients needing further
irrigation were also excluded.
Postoperative pain severity was assessed and recorded
using an 11-point visual analogue scale (VAS). The VAS was
given to each patient at the time of his/her arrival in the
recovery room, which was considered as hour 0. Each patient
recorded his/her pain tolerance at postoperative hours (h)
0, 2, 4, 8, 12, and 24. No pain scored 0 points, while worst
possible pain for the patient was scored with 10 points. The
pain scoring was reviewed by an anesthesiologist.
Table 1:Clinicalcharacteristicsofthepatientsaccordingtothetype
of anaesthesia.
Regional General P-value
Age (years) (mean ± S.D.) 69.76 ± 7.42 67.22 ± 10.14 NS
Stage (n)
No cancer 12 18
pTa-pT1 17 25 NS
pT2 13 11
Grade (n)N S
No cancer 12 18
GI-GII 16 16
GIII 14 8
NS: non signiﬁcant, M/F: male/female, VAS: visual analogue pain score,
median (range) and mean ± standard deviation (S.D.)
In cases with VAS scale score > 3 during the observation
period, 500mg of paracetamol combined with 20mg of
hyoskine N-butylbromide (Buscopan) were administered.
Stratiﬁcation of pain scoring was made using several
parameters, such as age, gender, stage, grade, and location
of the TCC’s.
Statistical analysis was performed using the SPSS 14.0 for
Windows statistical package (SPSS, Inc., Chicago, Il, USA).
Clinical and demographical characteristics were compared
using the Mann-Whitney U test for continues variables andISRN Urology 3
Table 2: Mean (range) (95% CI) VAS scale score from 0h to 24h in TUR-B patients according to tumor stage.
Hours 0 2 4 8 12 24
Negative 1.8 (0–7) 1.3 (0–5) 1.6 (0–6)∗ 1.3 (0–6) 0.6 (0–4)∗ 0.3 (0–2)
PTa-T1 0 (0–7)∗ 1.2 (0–5)∗ 0.9 (0–5)∗ 1.2 (0–5) 0.8 (0–8)∗ 0.1 (0–8)
PT2 6(0–8)+∗ 5 (0–10)+∗ 5 (0–10)+∗ 3.6 (0–8) 3.8 (0–8)+∗ 0 (0–8)
Kruscall Wallis <0.05, ∗Mann-Whitney P value <0.05 between groups, negative: no urothelial tumor found in specimen.
Table 3: Stratiﬁcation of mean (range) (95% CI) VAS score by bladder tumor location.
Trigone (n = 2 5 ) L a t e r a lw a l l( n = 26) Multiple tumors (n = 18) P-value
VAS at 0 h 0.64 ∗ (0.1–1.18) 1.54∗ (0.5–2.6) 4.06 (2.32–5.79) 0.002
VAS at 2 h 0.56 ∗ (0.15–0.97) 1.27∗ (0.44–2.1) 4.56 (2.69–6.43) <0.001
VAS at 4 h 0.6 ∗ (0.12–1.08) 1.35∗ (0.55–2.15) 4.44 (2.98–5.9) <0.001
VAS at 8h 0.96 (0.37–1.55) 1.08∗ (0.37–1.55) 3.56 (2.23–4.88) <0.001
VAS at 12h 0.68∗ (0.19–1.17) 0.96∗ (0.2–1.72) 3.56 (2.02–5.09) <0.001
VAS at 24 h 0.4 ∗ (−0.4–0.12) 0.15∗ (−0.7–0.37) 2.39 (0.73–4.04) 0.001
∗P < 0.05 versus multiple tumors.
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Figure 2: VAS scale score from 0h to 24h in TUR-B and TUR-P
patients stratiﬁed by the type of anesthesia (TUR-B: transurethral
bladder tumor resection, TUR-P: transurethral prostatectomy, R:
regional anaesthesia, G: general anaesthesia).
the chi-square test for categorical variables. Odds ratios
were used to quantify the strength of association between
variables. Kruskal-Wallis test was used to estimate equality of
population medians among groups and the Mann-Whitney
U test for comparison between the groups. The Spearman
correlation coeﬃcient (when appropriate) was used to
examine the independence between categorical variables.
Results were considered signiﬁcant if P<0.05.
3. Results
VAS scores, with 95% conﬁdence interval (CI) in relation
to postoperative time are shown in Figure 2. No statistical
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Figure 3: VAS scale score from 0h to 24h in TUR-B patients
according to tumor stage (Neg: negative pathology report).
diﬀerence was detected in the TUR-P patients at any
postoperative time between the two anaesthetic methods. In
the TUR-B patients, mean (95% CI) analogue VAS score
was greatest at 0h for general versus spinal anaesthesia
(P = 0.027). At 8h and 12h, general anaesthesia’s analgesic
eﬃcacy was increased signiﬁcantly (P = 0.017 and P =
0.007, resp.)
After adjusting for gender in the TUR-B group, male
patients under general anaesthesia experienced more pain at
0h and 2h [mean (95% CI), 1 (0–8) versus 0 (0–8) and 1 (0–
6) versus 0 (0–10), respectively (P = 0.021 and P = 0.032)].
However, in the female patients, VAS score was distributed
diﬀerently, since spinal versus general anaesthesia’s analgesic
eﬃcacywaslost at 4h [median (95% CI) 3 (0–4) versus 0 (0–
3)], 8h [2.5 (0–3) versus 0 (0–2)] and 12h [2 (0–2) versus 0
(0-1)] (P = 0.005, P = 0.004, P<0.001, resp.), suggesting a
better analgesic eﬃcacy for general anaesthesia.4 ISRN Urology
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Figure 4: VAS scale score from 0h to 24h in TUR-B patients
according to resected tumor volume.
A separate analysis was performed in male patients
comparing TUR-P versus TUR-B. No diﬀerence in VAS score
was recorded between the two surgical approaches when
general anaesthesia was chosen as analgesic method. In the
spinalgroup,however,TUR-Bpatientspresentedlowermean
VAS score than TUR-P patients at 0h [0 (0–8) versus 0.5
(0–5), (P = 0.007)]. This pattern changed at 8h [2.5 (0–8)
versus 0.5 (0–2) (P = 0.039)] and at 12h, [2 (0–8) versus 0
(0–2) (P = 0.016)].
Interestingly, after adjusting for the covariates stage and
gradeintheTUR-Bpatients,ahigherVASscorewasobserved
for pT2 patients compared to pTa, pT1 (TNM), and patients
with negative pathology report (Figure 3 and Table 2). Stage
and tumor grade were highly correlated (P<0.001), but
grade did not present any statistical signiﬁcance with VAS
score at any postoperative hour.
Resected tumor volume was used as a categorical vari-
able, and patients were divided in those with <10cm3 [mean
volume 3.3 (1–10), (n = 82)] and >10cm3 mean 28.1 (11–
40) (n = 15)]. The cut-oﬀ point of 10cm3 was set by
the statistical analysis. Those with resected tumor volume
> 10cm3 presented VAS score >2a t8 ha n d2 4 h ,w h i c h
was statistically signiﬁcant (P = 0.050, P = 0.036, resp.)
(Figure 4). Adjusting for the method of anaesthesia, subjects
with bladder tumors larger than 10cm3 that received general
anaesthesia presented VAS score <3 at 4h, (OR = 6 95%
CI 1.01–35.04, P = 0.035). However at 24h, VAS > 3w a s
more common in patients with tumor volume <10cm3 who
underwentgeneralanaesthesia(OR=3.595%CI1.09–11.02,
P = 0.008).
Finally, location of the bladder tumor was also examined.
Apart from the 24h, tumor located in the lateral bladder
walls induced more pain than those situated in the trigone.
Moreover, tumor multifocality had the highest VAS scores in
all observation periods (Table 3).
4. Discussion
The majority of published reports investigate the results
of general and spinal anaesthesia separately. Several papers
compare the eﬀect of these methods in terms of peri-
and postoperative morbidity (blood loss, side eﬀects, and
possible complications) [10]. To our knowledge, this is one
ofthefewattemptsofcomparingthe2methods byrecording
the patient’s pain perception and tolerance.
Several interesting and novel points were drawn from the
statistical analysis of our data. Firstly, in patients undergoing
TUR-P, we found that none of the 2 methods of anaesthesia
prevailed during the 24-hour observation period. Reeves and
Myles reported a similar result using a 5-point verbal rating
scale. This result however, described the satisfaction with
analgesia and not the pain level [11]. Another report by
Fredman and colleagues advocated general anaesthesia as the
method of choice in transurethral procedures [12]. Again,
patient satisfaction was recorded, but the main limitation
was that no adjustment for the type of the transurethral
procedure was made. Nott et al. suggested that regional
anaesthesia reduces the incidence of catheter-related pain,
although being of similar eﬃcacy to oral diazepam and thus
is more advantageous than general anaesthesia [13]. The
same eﬀect is produced by periprostatic nerve blockage [14].
On the other hand, diﬀerences were recorded in TUR-B
patients. To be more speciﬁc, spinal was more eﬃcient than
general anaesthesia in the ﬁrst 2h after surgery, while general
proved to be better in the later time points. This fact can
be explained by the major implications induced in bladder
functionbyregionalanesthesia.Indeed,catheter-relatedpain
and detrusor muscle spasm elicited by bladder irrigation can
be managed eﬃciently with regional anaesthesia in the ﬁrst
2 postoperative hours. However, it simultaneously causes a
clinically signiﬁcant disturbance of bladder function due to
interruption of the micturition reﬂex [15]. Additionally, it
has a greater eﬀect on bladder compliance and lowers the
intraabdominal pressure [16]. As a result, painful bladder
overdistention or even acute retention might occur after the
removal of the catheter, due to the long-lasting recovery
of the normal bladder function. Based on the clinical
experience, the incidence of such an event is rather rare, thus
we might implicate the catheter and bladder spasm as the
most distressing causes of postoperative pain. However, an
interesting analgesic approach could have been the combina-
tion of spinal anaesthesia with antimuscarinic pretreatment,
such as oxybutnin or tolterodine, or the administration of
gabapentin during general anaesthesia, which is shown to
signiﬁcantly reduce catheter-related pain [17, 18].
Theaboveurodynamiceﬀectsmightbeinterpretedbetter
in the female patients than in men, since in women there are
no prostatic symptoms that could bias the bladder pain, and
we should also acknowledge the fact that females perceive
pain better than men, as recent reports suggest [19]. In
the female population of our study, spinal was less eﬀective
than general anaesthesia after the ﬁrst 4 hours, verifying the
possible implications of regional anaesthesia in the female
bladder.ISRN Urology 5
A very surprising observation is exhibited in the statis-
tical analysis, concerning the bladder tumor stage. Patients
with higher stage experienced a higher level of pain than
the ones with localized disease (pTa-pT1). No adequate
explanation of this phenomenon is provided by the current
literature. One can speculate that inﬁltrative disease stim-
ulates more nociceptors (highly specialized free endings of
sensory nerve ﬁbers) [20]. Even though this is a random
result, we believe that it is worth mentioning, since it
exhibited statistical signiﬁcance, and it might motivate a
better anaesthetic approach of patients that present with
pT2 disease cystoscopically. It is obvious that veriﬁcation
is required for the analysis of a large cohort of patients,
which should be also stratiﬁed by the type of the applied
anaesthesia.
We also found that the resected bladder tumor volume
becomes a signiﬁcant parameter of pain induction after a
TUR-B, when more than 10cm3 are resected. It is rational to
believe that a larger traumatic surface elicits more pain. On
the other hand, when we adjusted our analysis to the type of
anaesthesia, general anaesthesia seemed to be more eﬃcient
at 4h and 24h. Tumor volume was the only parameter
favoring the eﬃciency of general anaesthesia independently
of the postoperative time of observation.
The use of VAS scale for the documentation of pain
m e a s u r e m e n ti n t r o d u c e sas t u d yb i a sp e rs e ,s i n c et h i si sa
subjective method. To date, no objective recording of pain
perception has been described, even though several pain
scales assessing the patient’s agitation level by recording the
facial expression, leg movement, and muscle tension, or
eventhebrainelectrophysiologicactivitythroughspecialized
electroencephalograms (EEG) are presented as promising
[21]. Yet, patient self-reporting of pain by verbal rating is
considered the gold standard [21]. The use of vital signs,
such as heart rate and arterial pressure or even pupil
reactions could reﬂect partially the pain status, but they
could be aﬀected also by the postsurgical stress, the patient’s
comorbidities, or the prescribed medication. Nevertheless,
clinically signiﬁcant diﬀerences between VAS scores might
be considered realistic anecdotally, when they exceed 4-5
points. Thus, in our study, clinical signiﬁcant diﬀerences
were observed in diﬀerent bladder tumor stages and multiple
versus single tumors.
One comment should be also made about pharmacoki-
netics. The dosage of epidural regimens has an eﬀect of
approximately one and a half hours. Therefore, it could
not have altered the VAS scoring, since the 0h point was
set at the arrival in the recovery room. The selection
of paracetamol and hyoskine N-butylbromide as rescue
analgesics in patients, reporting VAS > 3p o s t o p e r a t i v e l y ,w a s
made due to their immediate action and their short half-lives
[22,23],whichcouldnothaveaﬀectedtheperceptionofpain
during the 2-hour and 4-hour intervals of VAS recording.
This study is not without limitations. The patients were
not randomized due to the fact that the selection of analgesia
was made by the anaesthesiologists individually for each
patient, according to their performance status. Another
drawback could be the lack of analysis of the time of the
operation and the prostatic volume resected. Even though
the resected adenoma cannot be rationally associated with
pain induction, since the major causes of TUR-P pain are
bladder spasm, catheter-related pain, and capsule oﬀense,
a future study could incorporate this parameter. As for
the time of the operation, we believe that it could not
have aﬀected the result, since the scoring started after the
completion of the operation, during which pain is managed
suﬃciently.
5. Conclusions
The analysis of the advantages and disadvantages of regional
compared to general anaesthesia is immensely complicated.
As can easily be imagined, the secondary eﬀects of both
types of anaesthesia are varied, and realistically, they must
be considered for each and every patient, due to the
unique clinical proﬁles presented. This study attempted to
establishthepotencyofgeneralandspinalanaesthesiaduring
transurethral procedures by recording the patient’s pain
perception. It seems that spinal anaesthesia is more eﬀective
during the ﬁrst 2 postoperative hours, while general prevails
at later stages and at larger traumatic surfaces. Finally, we
incidentally found that tumor stage plays a signiﬁcant role in
postoperative pain, a point that requires further veriﬁcation.
We advocate a closer cooperation of the urologist with
the anaesthesiologist in terms of providing more speciﬁc
informationaboutthepatient’sdiseaseandtailoringthetype
of anaesthesia to the patient’s needs.
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